Recombinant human microplasmin: production and potential therapeutic properties-Reference-Cited by-同舟云学术

Recombinant human microplasmin: production and potential therapeutic properties

Published:2003-02 Issue:2 Volume:1 Page:307-313
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Nagai N.,Demarsin E.,Van Hoef B.,Wouters S.,Cingolani D.,Laroche Y.,Collen D.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1538-7836.2003.00078.x/fullpdf

Reference20 articles.

1. CLINICAL AND EXPERIMENTAL STUDIES ON FIBRINOLYTIC ENZYMES

2. THE USE OF PLASMIN IN HUMANS

3. 3 VJ Jensen, and US (inventor). patent 3,950,513. Process of stabilizing therapeutically useful plasmin solutions. Novo Terapeutisk Laboratorium (assignee). Issued 13 April, 1976 .

4. Depletion of circulating α2-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization

5. Role of Plasminogen System Components in Focal Cerebral Ischemic Infarction

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A simple and effective method to remove pigments from heterologous secretory proteins expressed in Pichia pastoris;Advanced Biotechnology;2024-02-08

2. A novel recombinant human microplasminogen induced complete posterior vitreous detachment without morphological change of retina in juvenile rabbits;Experimental Eye Research;2023-05

3. Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target;TH Open;2022-10

4. Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications;Current Medicinal Chemistry;2022-01

5. Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs;Experimental & Molecular Medicine;2021-10